Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  CSPC Pharmaceutical Group Ltd    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LTD (1093)
My previous session
Most popular
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
12/10/2018 12/11/2018 12/12/2018 12/13/2018 12/14/2018 Date
12.76 13.04 12.78 13.12 11.54 Last
62346096 39446844 39525622 35202854 111615658 Volume
-3.48% +2.19% -1.99% +2.66% -12.04% Change
Financials (HKD)
Sales 2018 21 137 M
EBIT 2018 4 601 M
Net income 2018 3 640 M
Finance 2018 5 073 M
Yield 2018 1,67%
Sales 2019 25 945 M
EBIT 2019 5 849 M
Net income 2019 4 645 M
Finance 2019 7 760 M
Yield 2019 2,11%
P/E ratio 2018 19,58
P/E ratio 2019 15,39
EV / Sales2018 3,17x
EV / Sales2019 2,48x
Capitalization 71 990 M
More Financials
Company
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs),... 
Sector
Pharmaceuticals
Calendar
03/27Earnings Release
More about the company
Surperformance© ratings of CSPC Pharmaceutical Group
Trading Rating : Investor Rating :
More Ratings
Latest news on CSPC PHARMACEUTICAL GROUP
11/14CSPC PHARMACEUTICAL GROUP LTD : quaterly earnings release
10/22HSI opens up 106 pts at 25,668; H-share up 51 pts at 10,273
AQ
09/26Verastem grants CSPC rights to Copiktra in China
AQ
09/13ASIA MARKETS: Asian Stock Markets Recover, Led By Japan And Hong Kong
DJ
09/13China biopharma stocks fall after centralized tendering talks
AQ
08/21ASIA MARKETS: Japan's Nikkei Drops As Yen Maintains Dollar Advantage
DJ
07/16HSI opens up 55 pts at 28,580; H-share up 11 pts to 10,757
AQ
07/12CSPC PHARMACEUTICAL : Shanghai Junshi licenses anti-PD-1 mAb to CSPC
AQ
07/11CSPC PHARMACEUTICAL : Pharma & Junshi to develop breast cancer drugs
AQ
07/05CSPC PHARMACEUTICAL : Pharma's fundamentals remain solid
AQ
More news
Analyst Recommendations on CSPC PHARMACEUTICAL GROUP
More recommendations
Sector news : Pharmaceuticals - NEC
04:36pDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Shire Plc
DJ
03:33pPFIZER : Kineta in Licensing Deal With Pfizer Potentially Worth More Than $500 M..
DJ
01:44pProteostasis in Licensing Pact With Roche's Genentech
DJ
01:01pMERCK AND : Gets EU OK for Keytruda as Adjuvant in Resected Stage III Melanoma
DJ
10:35aChina's Junshi Biosciences raises $394 million after pricing IPO at bottom of..
RE
More sector news : Pharmaceuticals - NEC
Chart CSPC PHARMACEUTICAL GROUP LTD
Duration : Period :
CSPC Pharmaceutical Group Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 36
Average target price 22,4  HKD
Spread / Average Target 94%
EPS Revisions
Managers
NameTitle
Dong Chen Cai Chairman & Co-Chief Executive Officer
Zhen Guo Wang Vice Chairman & Co-Chief Executive Officer
Wei Dong Pan Vice Chairman
Ka Sze Lee Secretary & Non-Executive Director
Huai Yu Wang Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CSPC PHARMACEUTICAL GROUP LTD-27.33%9 216
JOHNSON & JOHNSON-4.81%356 703
PFIZER20.93%254 040
NOVARTIS5.61%223 295
ROCHE HOLDING LTD.1.38%216 307
MERCK AND COMPANY35.92%198 877